Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,524 | 723 | 92.8% |
| Education | $1,285 | 6 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,704 | 108 | $0 (2024) |
| PFIZER INC. | $1,929 | 96 | $0 (2024) |
| Lilly USA, LLC | $1,562 | 59 | $0 (2024) |
| Janssen Biotech, Inc. | $1,358 | 51 | $0 (2024) |
| LEO Pharma Inc. | $1,255 | 98 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $986.59 | 25 | $0 (2024) |
| AngioDynamics, Inc. | $956.00 | 2 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $929.43 | 39 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $807.86 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $783.59 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,423 | 109 | ABBVIE INC. ($496.74) |
| 2023 | $2,669 | 121 | LEO Pharma Inc. ($431.75) |
| 2022 | $2,186 | 101 | LEO Pharma Inc. ($363.39) |
| 2021 | $1,624 | 81 | AbbVie Inc. ($277.81) |
| 2020 | $770.32 | 35 | Sun Pharmaceutical Industries Inc. ($163.83) |
| 2019 | $3,009 | 82 | AngioDynamics, Inc. ($660.00) |
| 2018 | $2,916 | 101 | Ortho Dermatologics, a division of Bausch Health US, LLC ($456.05) |
| 2017 | $2,212 | 99 | AbbVie, Inc. ($436.94) |
All Payment Transactions
729 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $30.90 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.73 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: Immunology | ||||||
| 12/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: DERMATOLOGY | ||||||
| 12/07/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $142.65 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Immunology | ||||||
| 11/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $77.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.04 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,062 | 4,360 | $406,565 | $176,197 |
| 2022 | 14 | 1,787 | 3,286 | $320,052 | $138,707 |
| 2021 | 11 | 1,520 | 3,158 | $266,089 | $119,203 |
| 2020 | 12 | 1,467 | 3,120 | $238,640 | $103,793 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 605 | 876 | $144,540 | $64,521 | 44.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 466 | 641 | $83,330 | $34,004 | 40.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 383 | 2,183 | $32,745 | $14,463 | 44.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 142 | 156 | $32,660 | $14,102 | 43.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 108 | 108 | $22,140 | $9,303 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 60 | $14,100 | $6,329 | 44.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 18 | 19 | $11,495 | $5,342 | 46.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 41 | 41 | $9,225 | $4,343 | 47.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 63 | 71 | $7,455 | $3,529 | 47.3% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 15 | 21 | $7,875 | $3,280 | 41.6% |
| 17273 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 16 | 18 | $7,290 | $3,223 | 44.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 24 | 24 | $5,640 | $2,711 | 48.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 16 | $5,520 | $2,679 | 48.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 36 | 43 | $4,515 | $2,198 | 48.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 12 | $3,900 | $1,986 | 50.9% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 13 | 15 | $9,000 | $1,985 | 22.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $2,860 | $1,414 | 49.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 20 | $2,200 | $767.32 | 34.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 25 | $75.00 | $19.58 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 553 | 781 | $128,865 | $57,621 | 44.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 420 | 520 | $67,600 | $27,882 | 41.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 145 | 145 | $29,725 | $11,771 | 39.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 112 | 125 | $26,250 | $11,463 | 43.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 331 | 1,446 | $21,690 | $9,531 | 43.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 36 | 41 | $9,225 | $4,188 | 45.4% |
About Dr. Susan Wolf, M.D
Dr. Susan Wolf, M.D is a Dermatology healthcare provider based in San Mateo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043206261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Wolf, M.D has received a total of $17,809 in payments from pharmaceutical and medical device companies, with $2,423 received in 2024. These payments were reported across 729 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($16,524).
As a Medicare-enrolled provider, Wolf has provided services to 6,836 Medicare beneficiaries, totaling 13,924 services with total Medicare billing of $537,901. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location San Mateo, CA
- Active Since 09/22/2005
- Last Updated 03/20/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1043206261
Products in Payments
- EUCRISA (Drug) $1,673
- TALTZ (Drug) $1,473
- DUPIXENT (Biological) $1,288
- SKYRIZI (Biological) $1,087
- Humira (Biological) $1,047
- ADBRY (Biological) $1,015
- EVLT (Device) $956.00
- COSENTYX (Biological) $693.38
- ILUMYA (Biological) $661.41
- TREMFYA (Drug) $603.36
- REMICADE (Biological) $436.62
- Otezla (Drug) $408.97
- OPZELURA (Drug) $374.59
- Tremfya (Drug) $330.68
- Cimzia (Drug) $324.89
- DORYX (Drug) $323.61
- RINVOQ (Biological) $306.95
- VTAMA (Drug) $281.87
- CIBINQO (Drug) $256.61
- Bimzelx (Biological) $252.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Mateo
Carie Chui, M.d, M.D
Dermatology — Payments: $9,745
Bruce Maltz, M.d, M.D
Dermatology — Payments: $8,628
Kerry Zandee Van Rilland, Md, MD
Dermatology — Payments: $7,481
Dr. Meghan Hession, Md, MD
Dermatology — Payments: $6,761
Peter Webb, M.d, M.D
Dermatology — Payments: $6,539
Alvin Li
Dermatology — Payments: $6,096